01 1Natco Pharma
01 1CHLOROQUINE PHOSPHATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-06-21
Pay. Date : 2019-06-14
DMF Number : 33067
Submission : 2019-02-20
Status : Active
Type : II
20
Natco Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CHLOROQUINE PHOSPHATE, with a corresponding US DMF Number 33067.
Remarkably, this DMF maintains an Active status since its submission on February 20, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 21, 2019, and payment made on June 14, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
